CoreWeave Stock Drops as Major Investor Magnetar Sells $500M+ in Shares
CoreWeave shares fall after top shareholder Magnetar Financial dumps over $500 million in stock within a week, despite previously praising the AI infrastructure company.
NOTRELOAD AI
JPMorgan Upgrades RAPT Therapeutics on Promising Drug Trial Results
JPMorgan raises RAPT stock rating to Overweight with $55 target after Phase 2 trial success. Stock jumps 17% on positive chronic urticaria treatment data.
Alto Neuroscience Gets $50M Boost and FDA Green Light for Depression Treatment
Baird raises Alto Neuroscience price target to $16 as company secures $50M funding and FDA approval to fast-track ALTO-207 depression drug development.
Riot Platforms Stock Target Raised: Bitcoin Mining Sites Eyed for AI Conversion
Piper Sandler ups Riot Platforms price target to $25, citing potential hyperscaler deals to convert Texas bitcoin mining facilities into AI data centers.
L'Oréal Acquires Kering Beauty for $4.66B: What It Means for the Luxury Market
L'Oréal buys Kering Beauty for $4.66B, gaining Creed and 50-year licenses for Gucci, Balenciaga beauty products. Coty faces major headwind losing Gucci brand.
Rani Therapeutics Stock Soars: Major Partnership and Funding Boost Shares to $10 Target
Maxim doubles Rani Therapeutics price target to $10 after $1B+ Chugai partnership validates RaniPill technology. Company secures $60M funding to advance oral drug delivery platform.